Metastatic Non-small Cell Lung Cancer (NSCLC) Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade
Metastatic Cutaneous MelanomaMetastatic Non-small Cell Lung Cancer (NSCLC)
EuroCityClinic LLC90 enrolled1 locationNCT07130032
Recruiting
Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients
Non-small Cell Lung Cancer MetastaticNon-small Cell Lung Cancer Stage IIMetastatic Non-small Cell Lung Cancer (NSCLC)
AIO-Studien-gGmbH12,400 enrolled1 locationNCT02622581